Breast Cancer

Latest News


By the time 14 months of treatment were through, I was watching a woman I no longer recognized and could not bear to look at in the mirror. I realized that to truly be a survivor, I had to readjust my expectations of myself.

Of all the things that cancer left me with, scarred veins in my only good arm has been the worst. I have learned to treasure those techs who can find a good vein and hit it the first time.

The Food and Drug Administration (FDA) has granted an approval to Trazimera (PF-05280014; trastuzumab-qyyp), a Herceptin (trastuzumab) biosimilar, to treat patients with HER2-overexpressing breast cancer as well as HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

Can at-home DNA testing kits accurately help us discover important health information? What do we do with the information once we receive it? In this post, learn more about the pros and cons.

The Food and Drug Administration has granted an accelerated approval to the frontline combination of Tecentriq (atezolizumab) plus Abraxane (nab-paclitaxel) for patients with unresectable locally advanced or metastatic PD-L1–positive triple-negative breast cancer (TNBC).